X @Bloomberg

Deal Overview - European private equity firm Keensight Capital agreed to acquire a majority stake in orthobiologic product maker Isto Biologics [1] - The acquisition is from Thompson Street Capital Partners [1] - The deal signifies a continuation of pickup in mid-sized deals [1]